References
- Sayed D, Deer TR, Tieppo Francio V, et al. American Society of Pain and Neuroscience Best Practice (ASPN) Guideline for the treatment of sacroiliac disorders. J Pain Res. 2024;17:1601–1638. PMID: 38716038; PMCID: PMC11075694. doi:10.2147/JPR.S464393
- Calodney A, Azeem N, Buchanan P, et al. Safety, efficacy, and durability of outcomes: results from SECURE: a single arm, multicenter, prospective, clinical study on a minimally invasive posterior sacroiliac fusion allograft implant. J Pain Res. 2024;17:1209–1222. doi:10.2147/JPR.S458334
- Hawila N, Berg A. Assessing the impact of COVID-19 on registered interventional clinical trials. Clin Transl Sci. 2021;14(3):1147–1154. PMID: 33769709; PMCID: PMC8212742. doi:10.1111/cts.13034
- Sayed D, Grider J, Strand N, et al. The American Society of Pain and Neuroscience (ASPN) Evidence-Based Clinical Guideline of interventional treatments for low back pain. J Pain Res. 2022;15:3729–3832. Erratum in: J Pain Res. 2022 Dec 24;15:4075–4076.. PMID: 36510616; PMCID: PMC9739111. doi:10.2147/JPR.S386879
- Deer TR, Grider JS, Pope JE, et al. Best practices for minimally invasive lumbar spinal stenosis treatment 2.0 (MIST): consensus Guidance from the American Society of Pain and Neuroscience (ASPN). J Pain Res. 2022;15:1325–1354. PMID: 35546905; PMCID: PMC9084394. doi:10.2147/JPR.S355285